Laryngotracheobronchitis, as the name implies, refers to inflammation of the larynx, trachea, and bronchi. Cases of laryngotracheobronchitis can be more severe than laryngotracheitis as the former extends into the lower airway. Both may be difficult to distinguish clinically.  The term "croup" colloquially describes both laryngotracheobronchitis and laryngotracheitis, and will, therefore, be used for the remainder of this article to describe this disease spectrum.
Croup is a very common cause of a cough, stridor, and hoarseness in children with a fever. Most children who have croup recover without any consequences. However, rarely, this infection can be lethal to infants.
Croup occurs more commonly in boys than in girls. It frequently occurs in children aged 6 months to 6 years old, with a peak incidence in children 12 months to 2 years of age. Most cases of croup occur from late autumn to early spring. Recurrent croup is rare unless there is a family history of the illness. Only a small percentage of patients require hospital admission. A population study conducted from 1999 to 2005 found that only 5.6% of children with croup required admission. Most patients can be safely discharged from the emergency department after appropriate management as discussed below.
Inhalation of the virus causing croup first infects the nasal and pharyngeal mucosal epithelia, then spreads to the subglottic space. For children 8 years and younger, the subglottic space is the most narrow part of the airway. The cricoid cartilage forms a complete cartilaginous ring that is nonexpanding. This inability of the cricoid to expand leads to a significant narrowing of the subglottic region secondary to the inflamed mucosa. When the child cries or becomes agitated, further dynamic obstruction can occur at and below the cartilaginous ring. These factors lead to the common high-pitched stridor heard at rest and when the patient becomes agitated. Extension into the bronchi, as occurs with laryngotracheobronchitis, can lead to wheezing, crackles, air trapping, and increased tachypnea; a clinical picture that can be confused with acute asthma.
One to three days of rhinorrhea, nasal congestion, and fever usually precedes croup. Typical symptoms of croup include a barky or a seal-like cough, hoarse voice, and high pitched inspiratory stridor that parents may incorrectly describe as “wheezing.”
Several scoring systems can evaluate the severity of respiratory distress. The Westley score assesses the following:
Evaluation of the patient must include ruling out other causes of stridor (discussed in the differential diagnosis section) and prompt recognition of the rapid progression or worsening of airway obstruction. Radiographs are not necessary to diagnose croup but can be obtained if the diagnosis is unclear. The “steeple sign,” due to subglottic narrowing, can be seen on plain films of the chest in patients with croup.
Patients should be evaluated while sitting comfortably on the caretaker's lap to prevent agitation and further narrowing of the airway. Croup is a clinical diagnosis made when patients present with a barky cough with or without stridor. Patients with the extension of inflammation into the lower airway, or laryngotracheobronchitis, can also have wheezing, crackles, decreased air movement, and tachypnea.
Patients with croup can be placed into 3 groups: mild, moderate, or severe, as seen in Table 1 below. Careful evaluation of worsening stridor, work of breathing (chest wall/subcostal retractions, nasal flaring, sitting in a sniffing position, suprasternal retractions, grunting, accessory muscle use), vitals, mental status, hydration status, and air movement help determine the treatment and disposition. The presence of wheezing, crackles, or decreased air movement on lung auscultation suggests laryngotracheobronchitis.
The goal of treatment is to decrease airway obstruction. Treatment includes nebulized epinephrine, corticosteroids, and at least 3 hours of observation after the last dose of epinephrine. Supplemental oxygen via blow by or nasal cannula can also be used for hypoxic patients with croup.
Racemic epinephrine 2.25% 0.05 mL/kg nebulized with a maximum of 5 mL or L-epinephrine 0.5 mL/kg nebulized with a maximum of 5 mL is reserved for moderate and severe croup. Admit patients requiring more than 1 to 2 doses of nebulized epinephrine in the emergency department.
Regardless of severity, all patients with croup benefit from oral steroids. Dexamethasone 0.15 mg/kg to 0.6 mg/kg by mouth with a maximum of 10 mg as a one-time dose is the typical dose (the intravenous dose can be given by mouth).
Patients with croup should be observed for a minimum of 3 hours after the completion of each dose of nebulized racemic epinephrine. Watch for worsening or recurrence of symptoms, including persistent stridor at rest, increased work of breathing, and hypoxia, during the observation period. Admit patients requiring more than one or two doses of nebulized epinephrine in the emergency department.
Several trials have been conducted on helion in the management of croup, and the results are mixed. Overall, there is no harm from trying heliox because most anecdotal reports indicate that it helps ease breathing.
Intubation is reserved for severe cases of croup not responding to medical treatment. The endotracheal tube size should be smaller than typical for the patient's age and size to avoid trauma to the already edematous airway.
For a patient younger than 6 months old with stridor:
For patients older than 6 months with stridor:
The prognosis for most children with croup is excellent. Most cases can be managed with outpatient care. Fewer than 2% of patients require hospitalization. The use of nebulized epinephrine and steroids has markedly lowered the need to intubate many patients.
Complications are rare but can occur in some cases. They include:
Patients with mild croup can be safely discharged from the emergency department with strict return precautions after receiving one dose of steroids. For patients with moderate or severe croup, important criteria to meet before discharge include observation for 3 hours after epinephrine without signs of worsening or recurrence of symptoms (persistent stridor at rest, increased work of breathing, hypoxia), the non-toxic appearance of the patient, and the patient's ability to tolerate oral liquids. Other factors to consider before discharge are that the caretaker recognizes an improvement in the child’s symptoms, the caretaker has adequate transportation to return if necessary, and there are no significant social issue concerns.
In any child with respiratory distress, a pediatrician should be consulted on the course of management. Consultation with an otolaryngologist may be advised if visualization of the larynx is indicated.
Washing hands is highly recommended.
Croup is a barky cough with or without stridor at rest.
Mild croup is a barky cough with or without stridor, with agitation. Treatment includes one dose of steroids then discharge home with strict return precautions.
Moderate croup is a barky cough and stridor at rest, with or without increased work of breathing. Treatment includes steroids and nebulized epinephrine with observation for at least 3 hours for reassessment.
Severe croup is a barky cough, stridor at rest, and prominent increased work of breathing. Treatment includes steroids and nebulized epinephrine with observation for at least 3 hours for reassessment. It will most likely include admission.
Evaluate for other dangerous diagnoses in the differential of upper airway obstruction.
Croup is managed by an interprofessional team that includes a pediatrician, emergency department physician, nurse practitioner, and radiologist. The diagnosis can be difficult because there is no specific test for the disorder. The goal of treatment is to decrease airway obstruction. Treatment includes nebulized epinephrine, corticosteroids, and at least 3 hours of observation after the last dose of epinephrine. Supplemental oxygen via blow-by or nasal cannula can also be used for hypoxic patients with croup. The majority of patients can be safely discharged home from the emergency department but the caretaker must be informed about the importance of avoiding smoking in the home. Other factors to consider before discharge are that the caretaker recognizes an improvement in the child’s symptoms, the caretaker has adequate transportation to return if necessary, and there are no significant social issue concerns.
|||Lee JH,Jung JY,Lee HJ,Kim DK,Kwak YH,Chang I,Kwon H,Choi YJ,Park JW,Paek SH,Cho JH, Efficacy of low-dose nebulized epinephrine as treatment for croup: A randomized, placebo-controlled, double-blind trial. The American journal of emergency medicine. 2019 Mar 8; [PubMed PMID: 30878411]|
|||Elder AE,Rao A, Management and outcomes of patients presenting to the emergency department with croup: Can we identify which patients can safely be discharged from the emergency department? Journal of paediatrics and child health. 2019 Feb 18; [PubMed PMID: 30779245]|
|||Lodeserto FJ,Lettich TM,Rezaie SR, High-flow Nasal Cannula: Mechanisms of Action and Adult and Pediatric Indications. Cureus. 2018 Nov 26; [PubMed PMID: 30740281]|
|||Moraa I,Sturman N,McGuire TM,van Driel ML, Heliox for croup in children. The Cochrane database of systematic reviews. 2018 Oct 29; [PubMed PMID: 30371952]|
|||Baillie VL,Olwagen CP,Madhi SA, Review on Clinical and Molecular Epidemiology of Human Rhinovirus-Associated Lower Respiratory Tract Infections in African and Southeast Asian Children. The Pediatric infectious disease journal. 2018 Jul; [PubMed PMID: 29893746]|
|||Gates A,Gates M,Vandermeer B,Johnson C,Hartling L,Johnson DW,Klassen TP, Glucocorticoids for croup in children. The Cochrane database of systematic reviews. 2018 Aug 22; [PubMed PMID: 30133690]|
|||Dalal R,Grujic D, Epinephrine 2019 Jan; [PubMed PMID: 29489283]|
|||Hilmes MA,Daniel Dunnavant F,Singh SP,Ellis WD,Payne DC,Zhu Y,Griffin MR,Edwards KM,Williams JV, Chest radiographic features of human metapneumovirus infection in pediatric patients. Pediatric radiology. 2017 Dec; [PubMed PMID: 28831577]|
|||Anderson-James S,Marchant JM,Chang AB,Acworth JP,Phillips NT,Drescher BJ,Goyal V,O'Grady KF, Burden and emergency department management of acute cough in children. Journal of paediatrics and child health. 2019 Feb; [PubMed PMID: 30066972]|
|||Ortiz-Alvarez O, Acute management of croup in the emergency department. Paediatrics [PubMed PMID: 29532807]|
|||Cutrera R,Baraldi E,Indinnimeo L,Miraglia Del Giudice M,Piacentini G,Scaglione F,Ullmann N,Moschino L,Galdo F,Duse M, Management of acute respiratory diseases in the pediatric population: the role of oral corticosteroids. Italian journal of pediatrics. 2017 Mar 23; [PubMed PMID: 28335827]|